Table 1.
Baseline characteristics and outcomes of patients diagnosed with coronavirus disease 2019 in one of two Chinese cohorts: consecutive patients with severe coronavirus disease 2019 and patients with critical coronavirus disease 2019 from Peking University Medical Team admitted from February 8 to 28, 2020 (Wuhan cohort) and all patients with coronavirus disease 2019 diagnosed in Shenzhen city and transferred to Shenzhen Third People’s Hospital from January 8 to February 25, 2020 (Shenzhen cohort)
| Clincal Characteristics | Total, n=555 | Wuhan, n=138 | Shenzhen, n=417 |
|---|---|---|---|
| Men, no. (%) | 269 (48) | 71 (51) | 198 (47) |
| Age, yr | 52 (36, 64) | 66 (54, 71) | 47 (34, 60) |
| Duration from onset of symptoms to admission, d | 5 (3, 11) | 14 (11, 18) | 4 (2, 7) |
| Disease severity at admission, no. (%) | |||
| Mild | 12 (2) | 0 (0) | 12 (3) |
| Moderate | 314 (57) | 0 (0) | 314 (75) |
| Severe | 194 (35) | 122 (88) | 72 (17) |
| Critical | 35 (6) | 16 (12) | 19 (5) |
| Concomitant diseases, no. (%) | |||
| Any | 198 (36) | 108 (78) | 90 (22) |
| Hypertension | 155 (28) | 92 (67) | 63 (15) |
| Diabetes | 53 (10) | 28 (20) | 25 (6) |
| Coronary heart disease | 41 (7) | 26 (19) | 15 (4) |
| COPD or asthma | 34 (6) | 21 (15) | 13 (3) |
| CKDa | 10 (2) | 9 (7) | 1 (0.2) |
| Malignant tumor | 4 (1) | 3 (2.2) | 1 (0.2) |
| Outcome, no. (%) | |||
| Death | 27 (5) | 24 (17) | 3 (0.7) |
| Progression to critical illnessb | 40 (8) | 18 (15) | 22 (6) |
COPD, chronic obstructive pulmonary disease.
CKD was defined as abnormalities of kidney structure or function, present for >3 months, according to the 2012 Kidney Disease Improving Global Outcomes CKD definition on the basis of the past medical history reported by the patients along with their medical records when available.
Patients who were critical at admission were excluded for the outcome of disease progression to critical illness (n=35).